Sumitomo Mitsui Trust Group
SRTA

Sumitomo Mitsui Trust Group’s Strata Critical Medical Inc SRTA Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.92M Sell
1,654,361
-23,187
-1% -$112K ﹤0.01% 696
2025
Q4 		$8.07M Sell
1,677,548
-151,073
-8% -$731K ﹤0.01% 698
2025
Q3 		$9.25M Sell
1,828,621
-1,170,571
-39% -$5.17M 0.01% 687
2025
Q2 		$12.1M Hold
2,999,192
– – 0.01% 660
2025
Q1 		$8.19M Sell
2,999,192
-101,481
-3% -$364K 0.01% 705
2024
Q4 		$13.2M Sell
3,100,673
-659,089
-18% -$2.51M 0.01% 688
2024
Q3 		$11.1M Sell
3,759,762
-300,520
-7% -$957K 0.01% 703
2024
Q2 		$14.1M Buy
4,060,282
+381,308
+10% +$1.27M 0.01% 683
2024
Q1 		$10.5M Sell
3,678,974
-295,318
-7% -$911K 0.01% 763
2023
Q4 		$14M Sell
3,974,292
-285,969
-7% -$821K 0.01% 744
2023
Q3 		$11M Sell
4,260,261
-264,831
-6% -$930K 0.01% 770
2023
Q2 		$17.8M Sell
4,525,092
-257,547
-5% -$817K 0.01% 726
2023
Q1 		$16.2M Sell
4,782,639
-58,776
-1% -$240K 0.01% 741
2022
Q4 		$17.3M Sell
4,841,415
-32,366
-0.7% -$138K 0.01% 736
2022
Q3 		$19.6M Sell
4,873,781
-53,754
-1% -$276K 0.02% 701
2022
Q2 		$22M Buy
+4,927,535
New +$35.6M 0.02% 704
2022
Q1 		– Sell
-4,332,774
Closed -$38.3M – 1184
2021
Q4 		$38.3M Buy
4,332,774
+1,110,780
+34% +$10.6M 0.02% 616
2021
Q3 		$33.5M Buy
3,221,994
+1,575,574
+96% +$13.8M 0.02% 636
2021
Q2 		$17.3M Buy
1,646,420
+711,464
+76% +$7.02M 0.01% 742
2021
Q1 		$9.62M Buy
934,956
+919,355
+5,893% +$12.8M 0.01% 786
2020
Q4 		$173K Buy
+15,601
New +$159K ﹤0.01% 1110

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group's SRTA Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group reduced its Strata Critical Medical Inc (SRTA) stake by 1.4% in Q1 2026, selling an estimated $112K and leaving 1,654,361 shares worth $6.92M. The position accounts for ﹤0.01% of the portfolio, ranked #696.

Sumitomo Mitsui Trust Group first reported a position in SRTA in Q4 2020 and has held it in 21 quarters since. The position peaked at $38.3M in Q4 2021. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Sumitomo Mitsui Trust Group held 1,654,361 shares of Strata Critical Medical Inc worth $6.92M as of Q1 2026.
  • Sumitomo Mitsui Trust Group sold 23,187 Strata Critical Medical Inc shares in Q1 2026, an estimated $112K.
  • Strata Critical Medical Inc made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #696 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Strata Critical Medical Inc in Q4 2020 and has held it in 21 quarters since.
  • Sumitomo Mitsui Trust Group's Strata Critical Medical Inc position peaked at $38.3M in Q4 2021.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.